ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx
December 13, 2021Qiming Venture Partners' portfolio company CANbridge Pharmaceuticals (SEHK: 1228), a leading China-based global rare disease-focused biopharmaceutical company, today listed on the main board of Hong Kong, S.A.R., China Stock Exchange. -
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX
September 28, 2020Qiming's portfolio company Zai Lab, an innovative commercial-stage biopharmaceutical company, officially listed on the Main Board of The Stock Exchange of Hong Kong, S.A.R., China Limited today.
Pharma Sources Insight January 2025
